Search results
Eli Lilly's Alzheimer's Drug, Donanemab Faces FDA's Adcomm Vote Next Week On Data, Risk Profile
Benzinga via Yahoo Finance· 1 hour agoIn March last year, Eli Lilly released the results of the TRAILBLAZER-ALZ 2 Phase 3 study of...
Understanding the effect genetics have on Alzheimer's
The Buffalo News· 1 hour agoContributor content. Understand the hereditary and non-genetic variables that influence the...
June Is Alzheimer's And Brain Awareness Month | NewsRadio WIOD | Florida News
iHeartRadio· 10 hours agoPurple is the color of June, in observance of Alzheimer’s Awareness Month. Worldwide, more than 55 million people are living with Alzheimer's or another ...
Is there genetic testing for Alzheimer’s disease?
St. Louis Post-Dispatch· 1 hour agoLee Enterprises newsroom and editorial were not involved in the creation of this content. If someone in your family has ever suffered from Alzheimer’s,...
Who is V. Stiviano? 'Clipped' highlights some fact and fiction about Donald Sterling's former...
Sporting News· 2 days agoV. Stiviano was in the headlines of every major media news outlet during the 2014 Donald Sterling...
In review of Lilly Alzheimer’s drug, FDA staff focus on safety, patient selection
BioPharma Dive via Yahoo Finance· 5 hours agoThe agency is seeking input from an advisory panel on whether donanemab is effective across...
Data from MRI can predict who will get Alzheimer’s and when, researchers say
Courthouse News Service· 10 hours agoThe neurodegenerative disease is the leading cause of dementia, is responsible for the death of more...
'Chopped'-winning celeb chef who didn't pay rent for over 4 years gets evicted
INSIDER via Yahoo News· 20 hours agoIn Texas, a man bought a home for $175,000 only to find the previous occupant still living there....
Ronald Reagan's principles, patriotism remembered 20 years after his death at legacy celebration
Fox News· 9 hours ago"It's valuable to reflect on the tremendous successes of the Reagan presidency and to draw lessons...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 3 days agoThe FDA delayed its decision on whether to approve the antiamyloid agent back in March, opting...